← back to search

Feng Li

Qingdao University · CN
Area of research
Pharmacology · Oncology
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Liver Disease Diagnosis and Treatment, and Lung Cancer Treatments and Mutations.
h-index
62
citations
15,460
works
479
NIH funding
primary concept
email

Recent publications

Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
The Lancet Diabetes & Endocrinology 2025cited by 5position: middledoi
The role of circadian clock in regulating cell functions: implications for diseases
MedComm 2024cited by 26position: lastdoi
Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis
Hepatology 2023cited by 27position: middledoi
DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors
Communications Chemistry 2023cited by 17position: middledoi
Assessment of abuse potential of carfentanil
Addiction Biology 2023cited by 15position: middledoi
Additional file 6 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Open MIND 2023cited by 0position: middledoi
Additional file 5 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Figshare 2023cited by 0position: middledoi
Additional file 2 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Figshare 2023cited by 0position: middledoi
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein
Nanomedicine Nanotechnology Biology and Medicine 2022cited by 32position: lastdoi
MicroRNA-20a-5p inhibits the autophagy and cisplatin resistance in ovarian cancer via regulating DNMT3B-mediated DNA methylation of RBP1
Reproductive Toxicology 2022cited by 32position: middledoi
Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer
Scientific Reports 2022cited by 23position: middledoi
BMAL1 regulates <i>Propionibacterium acnes</i>-induced skin inflammation via REV-ERBα in mice
International Journal of Biological Sciences 2022cited by 22position: firstdoi
Dysregulated hepatic UDP-glucuronosyltransferases and flavonoids glucuronidation in experimental colitis
Frontiers in Pharmacology 2022cited by 10position: middledoi
A transgenic zebrafish for <i>in vivo</i> visualization of cilia
Open Biology 2022cited by 6position: middledoi
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates CYP2A5 and Metronidazole Disposition
Molecular Pharmaceutics 2022cited by 5position: middledoi
Reverse Transcription Recombinase Polymerase Amplification Coupled with CRISPR-Cas12a for Facile and Highly Sensitive Colorimetric SARS-CoV-2 Detection
Analytical Chemistry 2021cited by 251position: middledoi
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
Nature Communications 2020cited by 204position: middledoi
Targeting REV-ERBα for therapeutic purposes: promises and challenges
Theranostics 2020cited by 150position: middledoi
The Mechanosensitive Ion Channel Piezo Inhibits Axon Regeneration
Neuron 2019cited by 210position: middledoi
Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment
Theranostics 2019cited by 135position: middledoi
Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis
Molecular Therapy 2019cited by 123position: middledoi
Diffuse cavernous hemangioma of the skull misdiagnosed as skull metastasis in breast cancer patient: one case report and literature review
BMC Cancer 2019cited by 7position: middledoi
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Journal of Clinical Investigation 2018cited by 260position: middledoi
EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer
Neoplasia 2018cited by 20position: middledoi
Quantitative real-time imaging of glutathione
Nature Communications 2017cited by 270position: middledoi
Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys
Nature Communications 2017cited by 186position: middledoi
G‐protein‐coupled bile acid receptor plays a key role in bile acid metabolism and fasting‐induced hepatic steatosis in mice
Hepatology 2016cited by 141position: middledoi
Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders
Journal of Lipid Research 2016cited by 116position: middledoi
Autophagy Induction by Silibinin Positively Contributes to Its Anti-Metastatic Capacity via AMPK/mTOR Pathway in Renal Cell Carcinoma
International Journal of Molecular Sciences 2015cited by 55position: firstdoi
Tumor necrosis factor-alpha is a potential diagnostic biomarker for chronic neuropathic pain after spinal cord injury
Neuroscience Letters 2015cited by 36position: middledoi

Grants

EPSCoR Research Fellows: NSF: Heterogeneous Integration of Wide Bandgap Semiconductor Chips for High Temperature Applications
NSF2429402$299,9382025–2026PIRePORTER
CyberCorps Scholarship for Service: Building the Next Generation Cybersecurity Engineering Workforce
NSF2436733$2,370,7502024–2028PIRePORTER
REU Site: Enhancing Undergraduate Experiences in Data and Mobile Cloud Security
NSF2431725$469,9992024–2027PIRePORTER
REU Site: Enhancing Undergraduate Experiences in Data and Mobile Cloud Security
NSF2349233$469,9992024–2024PIRePORTER
CyberCorps Scholarship for Service: Building the Next Generation Cybersecurity Engineering Workforce
NSF2146359$2,172,6002022–2024PIRePORTER
REU Site: Enhancing Undergraduate Experiences in Mobile Cloud and Data Security
NSF1852105$411,0002018–2024PIRePORTER
REU Site: Enhancing Undergraduate Research Experiences in Mobile Cloud Security
NSF1560020$395,0002016–2022PIRePORTER
IUSE: Collaborative Project: Building Virtual Research, Interactive, Service, and Experiential Learning Modules for Cyber Security Education
NSF1431330$287,1592014–2019PIRePORTER
Student Travel Support for the MobiHoc (ACM International Symposium on Mobile Ad Hoc Networking and Computing) 2014 Conference
NSF1432905$15,0002014–2015PIRePORTER
SBIR Phase II: ION Gate Membrane For High Performance Redox Flow Batteries
NSF1329730$601,1162013–2016PIRePORTER
REU Site: Enhancing Undergraduate Experience in Mobile Computing Security
NSF1262984$359,9642013–2017PIRePORTER
Collaborative Project: Building An Innovative Smartphone Virtual Laboratory Environment for Cyber-security Education and Training
NSF1303325$103,1952013–2017PIRePORTER
SBIR Phase I: ION Gate Membrane For High Performance Redox Flow Batteries
NSF1142695$149,3802012–2012PIRePORTER
SBIR Phase I: A Novel Membrane for Hydrogen Separation
NSF0610572$99,9232006–2007PIRePORTER
SBIR Phase I: Enhanced Organic Electroluminescent Display
NSF9860356$99,7331999–1999PIRePORTER

Frequent collaborators

Rui Gao · Zhejiang A & F University3 papers (2023–2023)Jianxing He · First Affiliated Hospital of Guangzhou Medical University3 papers (2023–2023)Yuewen Gao · Union Hospital3 papers (2023–2023)Yi Lu · China Pharmaceutical University3 papers (2023–2023)Zhixuan You · Nanchang University3 papers (2023–2023)Zhenyu Huo · Guangzhou Medical University3 papers (2023–2023)Caichen Li · National Clinical Research Center for Digestive Diseases3 papers (2023–2023)Wenhua Liang · Hebei Medical University3 papers (2023–2023)Ran Zhong · Southern Medical University3 papers (2023–2023)Fan Ge · Nanjing University of Chinese Medicine3 papers (2023–2023)Hengjia Tu · Guangzhou Medical University3 papers (2023–2023)Yanke Lin · Guangzhou University of Chinese Medicine2 papers (2020–2024) · 2 papers (2016–2016)Wenhai Fu · Guangzhou Medical University2 papers (2023–2023)Meng C. Wang · Boston University2 papers (2017–2020)Yuting Cai · University of California, Berkeley2 papers (2022–2024)Baojian Wu · Sun Yat-sen University2 papers (2020–2022) · 2 papers (2016–2016)Wanying Zeng · Guangzhou University of Chinese Medicine2 papers (2022–2022)Jin Wang · Henan Medical University2 papers (2017–2020)